• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

EXP Pharmaceutical Inc

Anonymous

Guest
I am interviewing with, from what I can tell a great company. DOes anyone know anything about them or how successful one can be commission wise in reverse distribution?